DH icon

Definitive Healthcare

3.99 USD
-0.07
1.72%
At close Aug 25, 4:00 PM EDT
After hours
3.99
+0.00
0.00%
1 day
-1.72%
5 days
1.53%
1 month
-2.68%
3 months
21.65%
6 months
-19.72%
Year to date
-3.16%
1 year
-12.88%
5 years
-90.78%
10 years
-90.78%
 

About: Definitive Healthcare Corp is a provider of healthcare commercial intelligence. Its SaaS-based healthcare commercial intelligence platform is designed to provide comprehensive and accurate information on the healthcare ecosystem in the U.S. The platform uses deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers, and improving win rates with detailed contextual information. The company derives substantially all of its revenue from the sale of subscription fees for access to its platform and stand-ready support. Geographically, it derives a majority of its revenue from the United States.

Employees: 782

0
Funds holding %
of 7,429 funds
Analysts bullish %

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

29% more capital invested

Capital invested by funds: $295M [Q1] → $382M (+$86.2M) [Q2]

28% more repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 36

0.63% more ownership

Funds ownership: 90.54% [Q1] → 91.16% (+0.63%) [Q2]

0% more funds holding in top 10

Funds holding in top 10: 1 [Q1] → 1 (+0) [Q2]

13% less funds holding

Funds holding: 136 [Q1] → 119 (-17) [Q2]

37% less first-time investments, than exits

New positions opened: 22 | Existing positions closed: 35

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
$6
50%
upside
Avg. target
$6
50%
upside
High target
$6
50%
upside

1 analyst rating

positive
100%
neutral
0%
negative
0%
Stifel
David Grossman
50%upside
$6
Buy
Maintained
8 Aug 2025

Financial journalist opinion

Based on 4 articles about DH published over the past 30 days

Positive
Zacks Investment Research
6 days ago
DH vs. BL: Which Stock Should Value Investors Buy Now?
Investors interested in stocks from the Internet - Software sector have probably already heard of Definitive Healthcare Corp. (DH) and BlackLine (BL). But which of these two stocks offers value investors a better bang for their buck right now?
DH vs. BL: Which Stock Should Value Investors Buy Now?
Neutral
Seeking Alpha
2 weeks ago
Definitive Healthcare Corp. (DH) Q2 2025 Earnings Call Transcript
Definitive Healthcare Corp. (NASDAQ:DH ) Q2 2025 Earnings Conference Call August 7, 2025 5:00 PM ET Company Participants Casey Heller - Chief Financial Officer Jonathan Paris - Chief Legal Officer Kevin D. Coop - CEO & Director Conference Call Participants David Michael Grossman - Stifel, Nicolaus & Company, Incorporated, Research Division George Robert Hill - Deutsche Bank AG, Research Division Johnathan M.
Definitive Healthcare Corp. (DH) Q2 2025 Earnings Call Transcript
Positive
Zacks Investment Research
2 weeks ago
Definitive Healthcare Corp. (DH) Q2 Earnings and Revenues Top Estimates
Definitive Healthcare Corp. (DH) came out with quarterly earnings of $0.07 per share, beating the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.09 per share a year ago.
Definitive Healthcare Corp. (DH) Q2 Earnings and Revenues Top Estimates
Neutral
GlobeNewsWire
2 weeks ago
Definitive Healthcare Reports Financial Results for Second Quarter Fiscal Year 2025
FRAMINGHAM, Mass., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced financial results for the quarter ended June 30, 2025.
Definitive Healthcare Reports Financial Results for Second Quarter Fiscal Year 2025
Neutral
GlobeNewsWire
1 month ago
Definitive Healthcare Announces Timing of Its Second Quarter 2025 Financial Results Conference Call and Webcast
FRAMINGHAM, Mass., July 24, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that it will report financial results for its second quarter ended June 30, 2025, on Thursday, August 7, 2025 after market close.
Definitive Healthcare Announces Timing of Its Second Quarter 2025 Financial Results Conference Call and Webcast
Neutral
GlobeNewsWire
1 month ago
Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4)
FRAMINGHAM, Mass., July 01, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that in connection with the hiring of two senior leaders, the Human Capital Management and Compensation Committee (the “Committee”) of Definitive Healthcare's Board of Directors granted inducement awards. The Committee granted Jeannine Lombardi, Definitive Healthcare's new Chief Human Resource Officer, an inducement award consisting of 421,349 time-based restricted stock units (“RSUs”), and Jonathan Paris, Definitive Healthcare's new Chief Legal Officer, an inducement award consisting of 421,349 time-based RSUs, each effective July 1, 2025. Each of these awards was individually negotiated and was granted as an inducement material to Ms. Lombardi's and Mr. Paris's respective commencement of employment with Definitive Healthcare in accordance with Nasdaq Listing Rule 5635(c)(4).
Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4)
Neutral
GlobeNewsWire
2 months ago
Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4)
FRAMINGHAM, Mass., June 03, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare market data and analytics, today announced that in connection with the hiring of a senior leader, that the Human Capital Management and Compensation Committee (the “Committee”) of Definitive Healthcare's Board of Directors granted an inducement award.
Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4)
Neutral
Seeking Alpha
3 months ago
Definitive Healthcare Corp. (DH) Q1 2025 Earnings Call Transcript
Definitive Healthcare Corp. (NASDAQ:DH ) Q1 2025 - Earnings Conference Call May 8, 2025 5:00 PM ET Company Participants Matthew Ruderman - Investor Relations Kevin Coop - CEO Rick Booth - CFO Casey Heller - SVP, Finance Conference Call Participants Jared Haase - William Blair Craig Hettenbach - Morgan Stanley David Grossman - Stifel George Hill - Deutsche Bank Jenny Shen - BTIG Operator Welcome to Definitive Healthcare's Q1 2025 Earnings Call. Later, we will conduct a question and answer session.
Definitive Healthcare Corp. (DH) Q1 2025 Earnings Call Transcript
Positive
Zacks Investment Research
3 months ago
Definitive Healthcare Corp. (DH) Beats Q1 Earnings and Revenue Estimates
Definitive Healthcare Corp. (DH) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of $0.02 per share. This compares to earnings of $0.08 per share a year ago.
Definitive Healthcare Corp. (DH) Beats Q1 Earnings and Revenue Estimates
Neutral
GlobeNewsWire
3 months ago
Definitive Healthcare Reports Financial Results for First Quarter Fiscal Year 2025
FRAMINGHAM, Mass., May 08, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced financial results for the quarter ended March 31, 2025.
Definitive Healthcare Reports Financial Results for First Quarter Fiscal Year 2025
Charts implemented using Lightweight Charts™